About: Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2006 (uk) artículu científicu espublizáu n'avientu de 2006 (ast) scientific article published on 01 December 2006 (en)
publication date	wds:Q79378918-9D7ACE32-227D-49E5-8B41-75A2DD947A91
publication date	2006-12-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q79378918-1A559ACA-AF51-4DF8-8964-ACB0D796C168 wds:Q79378918-3298861F-4A06-4240-986B-B5CF7FBE8126 wds:Q79378918-41AEC214-C9FB-473A-A919-73604557AEC3 wds:Q79378918-5614E8FA-76BE-47BD-ACA7-30B20F3FD2E1 wds:Q79378918-9BF13ADB-30CB-4B22-9D23-9027DC6EE955 wds:Q79378918-BEB05C66-7A7B-4B30-BD5D-BE4C575305A7 wds:Q79378918-C3C2155B-7BCA-46C5-8FCA-13FD49EB5081 wds:Q79378918-DC516C6F-D82D-4760-BAFC-0998BE6FE6EE wds:Q79378918-DD60E38A-8E28-43EA-96F7-45925B7A53E4
author name string	Robert Hunter Ann Harper Gary L Davis Richard B Freeman Goran Klintmalm John Vierling Jeffrey Punch Jamie Blazek Leslie Lieblein
rdfs:label	Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s (en) Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s (nl)
skos:prefLabel	Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s (en) Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s (nl)
name	Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s (en) Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s (nl)
author	wds:Q79378918-9A97EAD4-7046-419E-8F8A-9A9834E29116
author	Robert Gish
title	wds:Q79378918-733F1B46-5E4D-4E1A-9B94-E887CEE98462
title	Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula (en)
page(s)	wds:Q79378918-0FA18847-F0F5-4088-B8FE-37400DC94358
page(s)	S128-36
instance of	wds:Q79378918-C27AB59A-45D3-4117-90D5-785E915CA674
instance of	scholarly article
main subject	wds:Q79378918-0202261B-2D17-431C-AD60-915FAF649CD4 wds:Q79378918-589A7B29-788C-48DC-AFEF-CFB58804ED60
main subject	liver disease end-stage liver disease
PubMed ID	wds:Q79378918-E378201C-B7AE-46ED-90FB-3A2819859F28
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17123284
PubMed ID	17123284
published in	wds:Q79378918-9F0D9AC5-E5B6-40AC-AD67-7EAE35864ACF
published in	Liver Transplantation
issue	wds:Q79378918-02ADEC77-44BB-46BB-B938-051EC7C1AB91
volume	wds:Q79378918-37E79F67-229E-4332-A311-E05CCDC53948
issue	12 Suppl 3
volume	12
DOI	wds:Q79378918-5DE6CC2E-9139-4A25-8FC4-F19BAFC05161
DOI	http://dx.doi.org/10.1002/LT.20979
DOI	10.1002/LT.20979
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79378918
is cites work of	Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation MELD Exceptions and Rates of Waiting List Outcomes. Exception point applications for 15 points: an unintended consequence of the share 15 policy Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases Diagnosis and management of polycystic liver disease Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States Standardizing MELD Exceptions: Current Challenges and Future Directions Liver Transplantation for Cholestatic Liver Diseases in Adults Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board Model for end-stage liver disease-based organ allocation: managing the exceptions to the rules. Early changes in liver distribution following implementation of Share 35. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era MELD exceptions for portopulmonary hypertension: current policy and future implementation Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver Cirrhosis and autoimmune liver disease: Current understanding Matching Graft Quality to Recipient's Disease Severity Based on the Survival Benefit in Liver Transplantation Trends in liver transplantation 2011. Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era Fenestration of liver cysts in polycystic liver disease to improve quality of life: a case report and literature review Barriers to transplantation in adults with inborn errors of metabolism Correlation between selected prognostic factors and postoperative course in liver transplant recipients Impact of sepsis and non-communicable diseases on prognostic models to predict the outcome of hospitalized chronic liver disease patients Outcomes of Liver Transplant Recipients With Model for End-Stage Liver Disease Exception: Single-Center Experience in the Northeast of Brazil Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease Liver Transplantation for Patients with Cholestatic Liver Diseases Liver transplantation and autoimmune hepatitis MELD score, allocation, and distribution in the United States Laparoscopic surgery and polycystic liver disease: Clinicopathological features and new trends in management Treatment Barriers in Portopulmonary Hypertension Center differences in model for end-stage liver disease exceptions: fairness, local culture, and norms of practice Answers to multiple choice questions
is cites work of	wds:Q36320523-1BB1AFC8-329A-4C35-9F1B-74220656A4D3 wds:Q35977315-7DFDE891-16EF-4F5B-A6DA-C9FC5392A533 wds:Q38072284-978CC43E-637B-4086-8A1A-54BE2C0AA549 wds:Q37221494-5005033F-E131-42D6-AA5B-CDCD7F84255A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software